Neoadjuvant chemoradiotherapy to induce the expression of programmed death-ligand 1 of tumor cells and the infiltration of CD8+ lymphocytes in patients with rectal adenocarcinoma.
In a recent study published in Science Immunology, researchers investigated the CAMCI (combination of cell activation and metabolic checkpoint inhibition) strategy as an immunotherapeutic option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results